You are looking for

An exclusive roundtable hosted by Johnson & Johnson during this year’s Hauptstadtkongress debated the question whether the current healthcare system in Germany should compromise between the need to standardize treatments due to scarce resources and increasingly informed patients demanding the best treatment possible. Although panelists agreed that Germany may be leading in terms of standards […]

Listening to a distinguished panel of experts chaired by Bernard Merkel of DG Sanco I get the impression that things are moving to raise the level of patient safety. I was interested to learn that DG Sanco has commissioned a study to rate Member States in their efforts to combat patient safety. This “black list” […]

Just sitting at the airport after what was an excellent Global Harmonization Task Force Conference. Well done Steve Dibert and his crew, not to mention Health Canada. Who says regulatory affairs is boring! This conference really put the moose among the pigeons! We had a truly gripping opening session from Dr. Robert Jackson, the renowned […]

Sitting on Boston’s south shore, the John F. Kennedy Pesidential Library is both imposing yet not over-stated. A rare treat for me was the opportunity to address the annual meeting of MassMEDIC, the largest regional medical technology association in the USA – and that means the world, I am sure! The speaker’s podium has a […]

I’m just back from an extended trip to Sweden where I was invited to present at Swedish Medtech’s AGM (it was my first trip to Sweden so I tagged on a few days leave). Great event and a great country; if you haven’t visited yet, you have to go! I have always found Swedish people […]

Just back from Easter holidays and picked up this article from the Wall Street Journal “Medical Devices Face New Scrutiny From FDA”.  When I read the article it reminded me again of one of the great untold strengths of device regulation in Europe and yet another example where the European system is better than the […]

Brussels, 8 April 2009 – Eucomed welcomes revision of directive 2000/35/EC on Late Payments adopted by the European Commission today strengthening current payment obligations. Association disappointed to see final text considerably watered down compared to initial clear targets. As the voice of the medical technology industry in Europe, Eucomed is extremely pleased to see late […]

From 23 – 25 March 2009, the Drug Information Association (DIA) held its annual EuroMeeting in Berlin. During the presentation by Richard Moore, Institute of Nanotechnology, I learned that prescription drugs prove to be ineffective in 30% – 60% of patients1 and that 16% of the drugs approved in the USA are linked to severe […]

Today at the European Business Summit in Brussels a workshop was organized focusing on health entitled “Ageing and health: Pay for the grey”. The distinguished panel included Androulla Vassilliou, European Commissioner for Health, AGE, the European Older People’s platform, and the Japanese ambassador to the EU and last but not least industry representatives. Not surprisingly, […]